ArticleAntimicrobial agents and chemotherapy2026
Bridging clinical and environmental reservoirs: antimicrobial resistance in the emerging pathogen
Celia García-Rivera, Juan J Roda-Garcia, Juan Carlos Rodríguez, Carmen Molina-Pardines, Iryna Tyshkovska, Jose M Haro-Moreno, Antonio Martínez-Murcia, Maria Paz Ventero, Mario López-Pérez
Abstract read
In one paragraphArticle in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Celia García-RiveraMicrobiology Department, Alicante University General Hospital, Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain.
Juan J Roda-GarciaMicrobial Genomics and Evolution Group, División de Microbiología, Universidad Miguel Hernández, Alicante, Spain.
Juan Carlos RodríguezMicrobiology Department, Alicante University General Hospital, Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain.
Carmen Molina-PardinesMicrobial Genomics and Evolution Group, División de Microbiología, Universidad Miguel Hernández, Alicante, Spain.
Iryna TyshkovskaMicrobiology Department, Alicante University General Hospital, Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain.
Jose M Haro-MorenoMicrobial Genomics and Evolution Group, División de Microbiología, Universidad Miguel Hernández, Alicante, Spain.ORCID 0000-0002-2113-9269 Antonio Martínez-MurciaMicrobial Genomics and Evolution Group, División de Microbiología, Universidad Miguel Hernández, Alicante, Spain.
Maria Paz VenteroMicrobiology Department, Alicante University General Hospital, Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain.ORCID 0000-0003-1979-0949 Mario López-PérezMicrobial Genomics and Evolution Group, División de Microbiología, Universidad Miguel Hernández, Alicante, Spain.ORCID 0000-0002-3996-6780 Funding
Ministerio de Ciencia e Innovación PRE2021-098122Ministerio de Ciencia e Innovación PTA2021-020215-IMinisterio de Economía y Competitividad PID2023-150293NB-I00
6 · The paper itselfAbstract
The emergence of antimicrobial resistance in environmental bacteria threatens therapeutic efficacy in clinical settings.
Indexed as
Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialShewanellaCefiderocolDrug Resistance, BacterialHumansIntegronsMicrobial Sensitivity TestsPlasmidsAnti-Bacterial AgentsCefiderocolantibiotic resistanceantimicrobial resistancemobile genetic elementsmobile integronOne Healthpathogen emergenceShewanella algae
Identifiers
PMID41984096
PMCPMC13148052
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390